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Dyspnea is one of the main complaints of patients with cystic fibrosis (CF). Lung function at rest is not sufficient to explain dyspnea during
exercise. Because inspiratory muscles are faced with an increased workload in advanced CF, we studied the impact of their strength and endurance
on dyspnea and alveolar hypoventilation during exercise.
Methods: Eighteen stable CF patients performed a maximal exercise test on a cycloergometer. Level of exercise dyspnea was recorded by a Borg
scale at exhaustion. Blood gases were analysed at rest and at maximal peak exercise. Inspiratory muscle endurance (IME), expressed as a
percentage of maximal inspiratory pressure (PImax), was measured according to an incremental threshold loading technique (Martyn).
Results: Four men and fourteen women were included with a mean age of 32 years (20–67). Mean FEV1 was 44% predicted (21–82%). Mean
PImax was 78% predicted (24–148%). No significant correlation was found between dyspnea and age, body mass index, pulmonary function at
rest, blood gases, inspiratory muscle strength (PImax) or exercise capacity. Dyspnea was correlated with IME (r=−0.72, p=0.0029) and
plethysmographic airway resistance (r=0.64, p=0.009). When patients were grouped according to degree of exercise dyspnea, half expressed a
dyspnea more than “severe” (above level 5 on Borg scale) and half reported a lower dyspnea (Borg score≤5). Significant differences were
observed between these two groups in inspiratory muscle endurance (46.8 versus 76.4% of PImax; pb0.001), PaCO2 at rest (40.3 versus
36.2 mmHg; p=0.03) and PaCO2 at peak exercise (47.7 versus 40.6 mmHg; p=0.04).
Conclusion: Exertional dyspnea may be significantly influenced by inspiratory muscle function and alveolar hypoventilation in CF patients.
Inspiratory muscle endurance could be of importance to analyse the impact of pulmonary rehabilitation in this specific disease.
© 2011 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.Keywords: Dyspnea; Cystic fibrosis; Inspiratory muscle endurance; Exercise1. Introduction
Cystic fibrosis is a complex disease which affects several
physiological functions. Dyspnea is one of the primary
complaints of patients with CF. Lung function at rest is not
sufficient to explain dyspnea during exercise. Exercise capacity
has been identified as an independent determinant of mortality
in cystic fibrosis disease [1]. Thus it is relevant to explore⁎ Corresponding author. Tel.: +33 3 20 44 58 71; fax: +33 3 20 44 40 38.
E-mail address: sylvieleroy@yahoo.fr (S. Leroy).
1569-1993/$ - see front matter © 2011 European Cystic Fibrosis Society. Publishe
doi:10.1016/j.jcf.2010.12.006mechanisms responsible for exercise limitation and dyspnea.
Muscle endurance is the ability to sustain a specific muscular
task over time. It is a highly integrated and complex quality of
group of respiratory muscles which refers its resistance to
fatigue. Whether inspiratory muscle weakness is present or not
in CF patients remains controversial. A preserved inspiratory
muscle strength has been reported in previous studies,
suggesting a training effect of airway obstruction on inspiratory
muscles [2]. Lands and colleagues suggested that CF patients
are not able to maintain their inspiratory muscle strength in
advanced disease [3]. Other authors also found reduced
inspiratory muscle strength in CF patients [4]. Malnutritiond by Elsevier B.V. All rights reserved.
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muscle fatigue or dysfunction and therefore dyspnea. Inspira-
tory muscle training in adults with chronic obstructive
pulmonary disease has been published [5]. Whether or not
dyspnea is related to inspiratory muscle dysfunction in CF has
not been clearly demonstrated nor has the effect of inspiratory
muscle training in CF patients been fully explored. With this in
mind we initiated this prospective study to define the
relationship between dyspnea upon exercise and inspiratory
muscle performances, especially inspiratory muscle endurance
in CF.
2. Material and methods
2.1. Patients and study design
Eighteen CF adult patients (four males and fourteen
females), ranging in age from 20 to 67 years old, with a
diagnosis of cystic fibrosis were included in this monocentric
prospective study. Four patients had insulin-dependent diabetes
mellitus. All subjects except three had pancreatic insufficiency.
No patient received continuous oral corticosteroids. Inclusion
criteria for patients were an age over 18 years old, a CF
diagnosis [6], and stable clinical and lung function conditions
over the last two months. Exclusion criteria were acute
respiratory failure, oxygen therapy, coexisting heart or muscular
disease, pregnancy and uncontrolled diabetes. Medical man-
agement of the CF patients was carried out as normal, including
use of bronchodilators. A more extensive evaluation of
respiratory involvement was performed in these patients who
were all potential candidates to a rehabilitation program. It
included clinical examination, pulmonary function with inspi-
ratory muscle tests and an incremental exercise test based on a
cycle ergometry [7]. Informed consent was obtained from
patients and the study was approved by our local ethical
committee.
2.2. Clinical and nutritional evaluation
A detailed medical history was obtained, including the
presence of diabetes mellitus or pancreatic sufficiency. The
clinical evaluation also measured weight and height. Body mass
index (BMI) was calculated from the ratio of weight:height² (kg/
m²). Lean and fat body masses were assessed by bioimpedance
(ANALYCOR 5W®, Eugedia–Spengler, France) [8].
2.3. Pulmonary function
Standard pulmonary function tests were performed using
body plethysmography with a Jaeger® System (Jaeger-Mas-
terlab®, Germany). Bronchodilators, if previously prescribed,
were taken prior to lung function measurements and exercise
testing. Measurements of forced expiratory volume in one
second (FEV1), forced vital capacity (FVC), FEV1/FVC, total
lung capacity (TLC) and residual volume (RV) were compared
to ERS predicted values. Lung hyperinflation was defined by an
FRC above 120% of the predicted value [9,10].2.4. Dyspnea and exercise test
Cardiopulmonary exercise testing consisted of a triangular
test, carried out on an ergometric bicycle (Ergoline-Ergometrics
800®), with 10, 15 or 20 Watts per minute increments after a
warm-up period of three minutes at 20 W. Briefly the expired
gases were determined in each cycle with an Ergocard®. We
focused on oxygen consumption (VO2), carbon dioxide
production (VCO2), minute ventilation (VE) and tidal volume
(VT). Arterial blood sample were obtained from a small catheter
placed in the radial artery under local anesthesia. Measurements
of PaO2, PaCO2 and lactate were performed on room air at rest
and at peak exercise. The alveolar-arterial gradient in oxygen [P
(A-a)O2] was calculated from the alveolar gas equation. The
modified Bohr equation was used to calculate dead space to
tidal volume ratio (VD/VT). Predicted values for VO2 peak were
calculated from reference equations adapted to adult popula-
tions [11]. Maximum minute ventilation (MMV) was estimated
with the equation MMV=FEV1×40.
At the peak of exercise testing, patients were asked to rate the
subjective degree of dyspnea using the modified Borg scale
[12]. This scale is a validated indicator of the intensity of acute
dyspnea. It ranges from 0 to 10 where a value of 0 represents
“nothing at all”, 5 is synonymous with “severe” and 10 signifies
“maximal dyspnea”.
2.5. Evaluation of inspiratory muscle strength
Maximal inspiratory pressure (PImax) was measured with a
Volidyne® manometer connected to a mouthpiece with a small
leak (1 mm of diameter) to prevent glottic closure. Patients
remained seated during testing and measurements were
performed at FRC. PImax was determined as the maximal
inspiratory pressure sustainable for one second. Five to seven
trials were performed in each subject to obtain a coefficient of
variation below 10%. The highest value was used in the
analysis. Results of PImax were expressed in percentage
(PImax% pred) of the predicted value according to Uldry
[13]. Inspiratory muscle weakness was defined by a signifi-
cantly reduced PImax, considered below mean predicted —
1.64 SD. Thereafter, PImax being influenced by hyperinflation,
we calculated the decrease on PImax by liter of FRC increase
above predicted [14].
2.6. Inspiratory muscle endurance
Inspiratory muscle endurance (IME) was assessed by the
incremental threshold loading (ITL) test as previously described
with a modified commercial Threshold IMT® (Respironics)
device with a spring loaded valve [15–17]. The spring was
modified to produce inspiratory pressure loads up to 120 cm
H2O. Patients had to generate sufficient inspiratory pressure to
open the valve and allow inspiratory flow. Subjects started with
a low inspiratory load (20% of individual PImax) which was
subsequently increased at two minute intervals by steps
corresponding to 10% of their individual PImax. An adequate
inspiratory pressure plateau was verified in each patient by the
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was defined by the maximal inspiratory pressure sustained for
two minutes (Plim2). Results were expressed in absolute value
and as a percentage of PImax (Plim2/PImax). A low IME was
defined by a Plim2/PImaxb60%, according to values obtained
in our laboratory controls (Plim2/PImax 75.1±2.1%) and to
those obtained in other studies [15,18,19].
2.7. Statistical analysis
Numerical data were expressed as means±standard devia-
tion (SD), absolute values or percentages of predicted values.
Non parametric statistical tests were used due to the small
number of patients. Comparisons of quantitative data between
CF groups were made using Kruskal–Wallis and Mann–
Whitney U tests. The Wilcoxon signed rank test was used to
compare the data between rest values and exercise parameters.
Correlations between variables were assessed by the Spearman
test. Concerning regression analysis, it was done if fitting
statistical tests to a law could not reject that variables come from
a normal distribution. A p valueb0.05 was considered
statistically significant.
3. Results
Average values for baseline demographics data, resting lung
flows and volumes and arterial blood gases are displayed in
Tables 1 and 2. Anthropometric data reflected a preserved
nutritional status. Pulmonary function tests revealed a severe
obstructive ventilatory defect in this population with pulmonary
hyperinflation (15 patients had FRC above 120%) and moderate
hypoxemia. All patients performed respiratory muscles mea-
surements and incremental exercise testing.
3.1. Dyspnea
Dyspnea was assessed at peak exercise. No significant
correlation was found between dyspnea and age, body massTable 1
Anthropometric data and pulmonary function measurements at rest for all
patients.
18 patients
Characteristics Mean±SD Range
Gender, men/women 4/14
Age, years 32±12.6 20–67
BMI, kg/m2 19.8±1.9 17.2–22.7
Lean body mass,% 82.3±8.6 70.5–97
FEV1,% predicted 44.1±18.8 21–82
FEF25–75,% predicted 18.3±14.1 3–48
FVC,% predicted 61.6±19.8 37–113
TLC,% predicted 111±14.4 86–146
RV/TLC,% predicted 57±8 44.1–71.1
FRC,% predicted 141±23 106–195
Raw,% predicted 285±151 85–647
Definition of abbreviations: BMI = body mass index; FRC = functional residual
capacity; FVC = functional vital capacity; Raw = airways resistance; RV =
residual volume, TLC = total lung capacity.index, blood gases at rest, pulmonary hyperinflation or maximal
exercise capacity. Dyspnea was only correlated with plethys-
mographic airway resistance (r=0.64, p=0.009), Plim2/PImax
(r=−0.72, p=0.003) (Fig. 1), PImax (r=0.57; p=0.02), and
PaCO2 at maximum exercising (r=0.53; p=0.03). Dyspnea
was also significantly increased in patients with a decreased
IME (8 patients). Regression analysis indicated that IME
explains 48% of the variability in exercise dyspnea. The best
equation predicting dyspnea included IME and airway resis-
tance (Raw) was Borg rating=7.70858+0.00408969*Raw−
0.0466756*Plim2 /PImax (%).
When patients were grouped according to the level of their
exercise dyspnea, Group SvD represented eight patients with a
high level of dyspnea (Borg levelN5) and Group LwD consisted
of eight CF patients with a lower dyspnea (Borg levelbor=5).
No difference was observed between these two groups in terms
of anthropometric data or pulmonary flows and volumes.
Decreased IME and increased PaCO2 were associated with a
severe of dyspnea (Group LwD) (Figs. 1 and 2).
3.2. Inspiratory muscle measurements
Compared with predicted values, patients had a 22%
reduction in PImax. Because muscle shortening secondary to
hyperinflation is a likely mechanism, we calculated a decrease
of 5.2 cm H2O/l of FRC increase. If mean IME was normal in
this population, eight CF subjects had decreased values (Plim2/
PIMaxb60%). Furthermore, no linear correlation was observed
between PImax or IME and anthropometric data, pulmonary
function or blood gases at rest. Neither of these two parameters
were significantly correlated with peak exercise results (VO2,
Vt/FVC%, PaCO2, etc.). As noted before, the only data that
correlated with IME was dyspnea measured via the Modified
Borg scale. When patients were grouped according to their IME
(normal in 10 CF or decreased in 8 CF), the only differences
between groups were dyspnea and PaCO2 at rest and at peak
exercise. Thus, IME may be reduced in CF patients,
independently of their nutritional status, ventilatory obstructive
defect, pulmonary hyperinflation, inspiratory muscle strength or
maximal exercise capacity.
When patients were grouped according to the level of their
dyspnea, IME was significantly decreased in all but one patient
with a severe dyspnea (Group SvD). These data are presented in
Table 2 and Fig. 1. Concerning PImax, no differences between
groups were observed. Concerning PaCO2 at rest (36.3 versus
40.3 mmHg; p=0.03) and at peak exercise (40.6 versus
47.7 mmHg; p=0.04), they were significantly increased in
breathless patients (Group SvD) (Fig. 2).
3.3. Exercise tests and gas exchange
Aerobic capacity was significantly decreased in CF patients
(58.4% predicted). At peak exercise, subjects became more
hypoxemic and increased their PaCO2. Alveolar hypoventila-
tion (increase in PaCO2) and pulmonary gas exchange (increase
in P(A-a)O2) both contributed to arterial blood gazes
abnormalities. During exercise, patients progressively increased
Table 2
Inspiratory muscle parameters and blood gases analysis at rest for all patients and groups. Group SvD represented patients with a high level of exercise dyspnea (Borg
levelN5). Patients with a lower level of dyspnea (dyspnea rated less than 5 using a modified Borg scale) were in Group LwD.
Rest All patients Group SvD Group LwD Difference between groups
Characteristics Mean±SD Range Mean±SD Mean±SD P value
N 18 9 9
Exercise dyspnea 6±1.7 3–9 7.6±0.7 4.4±0.7 0.0001
PImax, cm H2O 69.8±28.7 29–129 78.7±30.8 61.0±24.9 NS
PImax,% predicted 78.4±34.1 23.4–148 87.4±35.5 69.4±32.0 NS
ΔPImax/FRC, cm H2O/l −5.2±6.5 −19.3–11.2
Plim2, cm H2O 41.3±18.3 12–93 37.1±15.5 45.6±20.8 NS
Plim2/PImax,% 61.5±20.3 26–106 46.8±11.2 76.4±15.8 0.0004
PaO2, mmHg 77.8±11.5 60.2–95.8 75.4±10.9 80.1±12.1 NS
PaCO2, mmHg 38.3±4.0 32.8–45.1 40.3±4.1 36.3±2.8 0.03
Definition of abbreviations: BMI = body mass index; FRC = functional residual capacity; FVC = functional vital capacity; Plim2 = inspiratory muscle endurance;
PImax = maximal inspiratory pressure; Raw = airways resistance; RV = residual volume, TLC = total lung capacity.
NS: difference between groups is not significant (pN0.05).
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volume to tidal volume ratio (VD/Vt) also increased during
effort and represented 34% of the peak tidal volume. At peak
exercise, ventilatory reserve was exhausted (11% at peak
exercise). When patients were grouped according to their
dyspnea level, no difference was observed in terms of maximal
workload, oxygen consumption, ventilation, and VD/Vt. These
results are presented in Table 3.
4. Discussion
There are three major findings in our study: 1) Exercise
dyspnea as expressed on a modified Borg scale was
significantly correlated with airway resistance, inspiratory
muscle strength and endurance and PaCO2, 2) IME and
PaCO2 were the only parameters which distinguished patients
with high or low level of exercise dyspnea, 3) IME may be0
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Fig. 1. Borg dyspnea at the end of the incremental exercise testing on a
cycloergometer as a function of the inspiratory muscle endurance (IME) expressed
as a percentage of maximal inspiratory pressure (Plim2/PImax%) (r=−0.72).
Triangles represent patients from Group LwD and squares represent patients from
Group SvD.reduced in CF patients, independently of their nutritional status,
ventilatory obstructive defect, pulmonary hyperinflation, inspi-
ratory muscle strength or maximal exercise capacity.
Our results strongly support the idea that the measure of IME
in addition to PImax is useful when evaluating determinants of
dyspnea. The difference in sensory experience of exertional
dyspnea in CF patients was accompanied by differences in IME.
This parameter assessed the endurance of all inspiratory
muscles, including rib cage muscles (RCM) and diaphragm.
The fact that IME was found to be correlated with dyspnea
suggests further studies are warranted to analyse the influence
of diaphragm or rib cage muscles fatigue. Breathing pattern and
respiratory muscle recruitment may also contribute to respira-
tory sensations like dyspnea [20]. Verges suggested that RCM
and not diaphragm fatigue seems to be responsible for rapidFig. 2. PaCO2 at rest and at peak exercise are represented for both groups. Group
A is represented by white rectangles. Group B is represented by grey rectangles.
Table 3
Results at peak exercise are presented for all patients and each group. Group SvD represented patients with a high level of exercise dyspnea (Borg levelN5). Patients
with a lower level of dyspnea (dyspnea under 5 at modified Borg scale) were in Group LwD.
Exercise All patients Group SvD Group LwD Difference
Characteristics Mean±SD Range Mean±SD Mean±SD P value
N 18 9 9
Exercise dyspnea 6±1.7 3–9 7.6±0.7 4.4±0.7 0.0001
Wpeak, % predicted 58.4±18.8 35–101 56.3±19.5 60.4±19 NS
VO2 peak, ml/min/kg 22.0±4.5 14.9–33.5 21.2±3.9 22.8±5.0 NS
PaO2 peak, mmHg 71.3±15.1 50.5–93.8 68.1±13.3 74.4±19.9 NS
PaCO2 peak, mmHg 44.1±5.9 32.3–56.2 47.7±5.4 40.6±7.0 0.04
P(A-a)O2 peak, mmHg 40±13 22–60 40±12 39±14 NS
Vtpeak, % FVC 48±10 30–66 49±11 47±8 NS
VEpeak, % predicted 89±21 45–117 90±19 88±24 NS
Vd/Vtpeak, % 34±8 21–45 34±8 33±8 NS
HFpeak, % predicted 81±12 67–109 83±13 80±11 NS
Definition of abbreviations: FVC = functional vital capacity, HF = heart frequency, Plim2 = inspiratory muscle endurance; P(A-a)O2 = alveolar-arterial gradient for
oxygen, PImax = maximal inspiratory pressure, VE = ventilation, Vd = dead volume, Vt = tidal volume, VO2peak = peak oxygen consumption, W peak = peak work
load.
NS: difference between groups is not significant (pN0.05).
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number of qualitatively distinct sensations that vary in intensity
and differ between CF patients and healthy subjects. Our study
suggested that IME could be one of the determinant factors for
dyspnea. Along this line, inspiratory muscle training is designed
to improve the performance of the respiratory muscles that may
be impaired in different respiratory diseases. Enright and
colleagues observed in 29 CF patients that IMT improved their
lung function and exercise capacity but dyspnea, assessed by a
questionnaire, was not modified by IMT [22]. Others authors
suggested that IMT resulted in increased muscle strength but
also in reduced sensation of inspiratory effort [23]. Though our
study did not answer the question of IMT impact, it suggests a
role for IME testing as a tool to select patients for such training
and evaluate its impact.
Evaluation of inspiratory muscle is not currently performed
in CF patients, maybe due to the lack of convincing data on its
clinical relevance. Strength and endurance of inspiratory
muscles have been measured using several methods. Measure-
ment of PImax has a poor repetability [24]. This has been
attributed to the day-to-day fluctuations in performance and the
different characteristics of the study populations under
investigation [25]. Furthermore, the improved coordination of
the respiratory muscles may be associated with learning effects
[26]. In addition to this, lung volume from which measure-
ments of inspiratory data are obtained, may affect the
reproducibility in patients with pulmonary hyperinflation
[27,28]. Enright and colleagues studied 20 CF patients. They
measured a coefficient of reliability above 89% with an
intraclass correlation coefficient of 0.88, indicating a high
reproducibility in this population. These results were similar in
healthy subjects [29].
Martyn developed an incremental threshold loading protocol
as an endurance test for inspiratory muscles [19,24]. This
technique has the advantage of not being affected by changes in
breathing rate and demonstrated a decreased IME in a variety ofrespiratory diseases: corticosteroid dependant asthma, COPD,
sarcoidosis, obesity [15,18,30].
Because inspiratory evaluation was limited to patients who
agreed to participate in a pulmonary rehabilitation program,
only 18 CF patients were enrolled in our overall CF treatment
cohort of one hundred patients. This small sample is a limitation
of our prospective study but interestingly our patients clearly
exhibited different level of dyspnea and of pulmonary function
abnormalities permitting analysis of statistical correlation.
Previous studies have reported a 15 to 40% reduction in
maximum static inspiratory mouth pressure in CF patients with
moderate airflow obstruction [27,31–33]. The present study
demonstrated a 22% reduction of PImax in adults CF patients
with moderate to severe obstructive ventilatory defect. The
decrease in PImax referred to FRC (5.2 cm H2O/l increase in
FRC) was similar to the reduction previously described in CF
patients (4.2 cm H2O/l for Pinet and colleagues) or COPD
patients (4.2 cm H2O/l for Similowski or 3.5 cm H2O/l Polkey)
[28,32,34]. The aetiologies of reduced inspiratory strength are
potentially multifactorial in CF, including hyperinflation,
malnutrition, and inflammatory factors that may contribute to
the decrease. In our study, we did not find significant
correlations between PImax and respiratory function or
nutritional data, but the size of the sample was small.
Few studies have focused on IME in CF populations. Whilst
PImax provides information on respiratory muscle strength, it
provides no insight into IME [35]. In normal subjects, IME
showed high inter-individual, but low intra-individual variabil-
ity. In healthy patients, Reiter did not find significant correlation
with PImax, age nor lung function at rest [36]. De Jong studied
sixteen CF patients whose IME was about 50% of PImax [37].
The decrease in IME did not correlate with standard pulmonary
function, exercise capacity nor nutritional status. In this study
as in ours, groups were too small to determine if gender had
an impact on IME preservation, but we found that IME may
be reduced independently of nutritional status, ventilatory
164 S. Leroy et al. / Journal of Cystic Fibrosis 10 (2011) 159–165obstructive defect, pulmonary hyperinflation, inspiratory mus-
cle strength or maximal exercise capacity.
Chronic respiratory insufficiency in CF is characterised by
an increase in respiratory load, which leads to alveolar
hypoventilation with the preservation of respiratory muscle
strength. This study could suggest that non invasive ventilation
can improve chest symptoms, exertional dyspnea and exercise
capacity [38].
In conclusion, our prospective study confirmed that dyspnea
in CF is multifactorial but it suggests that inspiratory muscles
and alveolar hypoventilation play an important role. Inspiratory
muscle endurance could be a relevant parameter to evaluate
exertional dyspnea in CF patients. Furthermore, it could be an
interesting parameter to evaluate the impact of respiratory
muscle training.
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